BRIEF published on 07/09/2024 at 07:04, 1 year 10 months ago Matthias Schupp Appointed as CEO of Medartis Medical Technology CEO Appointment Medartis Matthias Schupp
PRESS RELEASE published on 07/09/2024 at 06:59, 1 year 10 months ago Basel, 9th July 2024 Matthias Schupp appointed as CEO of Medartis Medartis appoints Matthias Schupp as CEO, succeeding Christoph Brönnimann. Schupp brings extensive experience in the medical technology sector CEO Appointment Leadership Transition Medartis Matthias Schupp Medical Technology Sector
BRIEF published on 06/11/2024 at 07:04, 1 year 11 months ago Medartis annonce la démission de son PDG Christoph Brönnimann Démission Du PDG Direction D'entreprise Transition D'entreprise Medartis Christoph Brönnimann
BRIEF published on 06/11/2024 at 07:04, 1 year 11 months ago Medartis Announces Resignation of CEO Christoph Brönnimann Corporate Leadership CEO Resignation Business Transition Medartis Christoph Brönnimann
PRESS RELEASE published on 06/11/2024 at 06:59, 1 year 11 months ago Basel, 11th June 2024 Medartis announces resignation of CEO Christoph Brönnimann Medartis Holding AG announces resignation of CEO Christoph Brönnimann. The Board initiates search for successor to ensure smooth transition and future growth Resignation CEO Successor Transition Medartis Holding AG
BRIEF published on 04/04/2024 at 07:30, 2 years 1 month ago Medartis Holding AG Successfully Places CHF 115.8 Million in Convertible Bonds Convertible Bonds Financial Strategy Medartis Holding AG Orthopaedic Surgery Investor Base Expansion
BRIEF published on 04/04/2024 at 07:30, 2 years 1 month ago Medartis Holding AG place avec succès 115,8 millions de CHF en obligations convertibles Stratégie Financière Liens Convertibles Chirurgie Orthopédique Medartis Holding AG Expansion De La Base D’investisseurs
PRESS RELEASE published on 04/04/2024 at 07:25, 2 years 1 month ago Medartis successfully places CHF 115.8 million convertible bonds due 2031 Medartis Holding AG successfully completes CHF 115.8 million convertible bond placement due 2031 for strategic business expansion and acquisitions. CFO Dirk Kirsten highlights growth opportunities Convertible Bonds Business Expansion Medartis Holding AG Funding Purposes Dirk Kirsten
BRIEF published on 04/03/2024 at 17:48, 2 years 1 month ago Medartis annonce une offre d'obligations convertibles de 115 millions de CHF Stratégie Financière Chirurgie Orthopédique Croissance Des Investissements Medartis Holding AG Offre D'obligations Convertibles
BRIEF published on 04/03/2024 at 17:48, 2 years 1 month ago Medartis Announces CHF 115 Million Convertible Bond Offering Investment Growth Financial Strategy Medartis Holding AG Convertible Bond Offering Orthopaedic Surgery
Published on 05/23/2026 at 19:45, 14 hours 21 minutes ago Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 1 day 6 hours ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 1 day 7 hours ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 1 day 7 hours ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 1 day 7 hours ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/24/2026 at 05:55, 4 hours 10 minutes ago The 26th CIFIT to Open in Xiamen This September, Preceded by Successful Guangzhou Roadshow
Published on 05/24/2026 at 05:35, 4 hours 30 minutes ago CGTN: Xizang at 75: Development and culture create a 'miracle on Earth'
Published on 05/23/2026 at 16:30, 17 hours 35 minutes ago HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 18 hours 9 minutes ago EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 1 day 12 hours ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 19:35, 1 day 14 hours ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day 16 hours ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day 16 hours ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 21 hours ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 21 hours ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
